The cumulative incidence of nasopharyngeal carcinoma per 100,000 person-years was 11.2 among subjects who had no serologic markers of EBV, 45.0 among those who had one marker, and 371.0 among ...

Nasopharyngeal cancer is a tumor of epithelial origin that typically originates in the pharyngeal recess of the nasopharynx. The multifactorial etiology of nasopharyngeal cancer includes genetic ...

These records were searched for several tumor markers at the time of cancer diagnosis (± 1.5 months), including CEA, CA 19-9, CA125, AFP, LDH, uric acid, and alkaline phosphatase. Results: A total of ...

A study led by clinician-scientists and researchers at the National Cancer Centre Singapore (NCCS) has found that the tumor ...

Nasopharyngeal carcinoma (NPC), a malignancy that develops in the upper section of the throat behind the nose, occurs in ...

Individuals who are at high risk for nasopharyngeal carcinoma may benefit from screening using circulating cell–free Epstein-Barr virus (EBV) DNA, suggest researchers from China. This cancer has ...

(NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the European Commission has approved TEVIMBRA ® (tislelizumab), in combination with gemcitabine and cisplatin, ...

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. P Bossi and others. Annals of Oncology, 2021. Volume 32, Issue 4, Pages 452-465.

The precise origin of nasopharyngeal cancer remains unclear, but researchers have identified several contributing factors. One of the primary nasopharyngeal cancer causes is infection with the ...

Nasopharyngeal cancer is when abnormal cells in the nasopharynx start to divide and grow in an uncontrolled way. The cells can grow into surrounding tissues or organs and may spread to other areas of ...